NYU Langone CEO Robert Grossman and board chair Ken Langone are retiring


Dr. Robert Grossman, NYU Langone’s CEO, and Kenneth Langone, chair of the board of trustees, are both set to retire next year, the health system said Thursday.

“It is immensely gratifying to know that we have transformed NYU Langone Health into an institution that is simply nonpareil,” said Grossman, who announced the leadership changes in an email to employees on Wednesday. “But all good things must come to an end.”

The executives will step down from their respective positions next August.

Grossman has led the institution since 2007, as NYU has become one of New York City’s highest-earning hospital systems. Last year, NYU Langone brought in more than $12 billion in revenue.

It has expanded over the past few decades to include six inpatient locations, the Perlmutter Cancer Center and 300 outpatient locations across the New York City region and Florida. Grossman also serves as the dean of the Grossman School of Medicine, and founded NYU’s Long Island medical school.

Langone, who became a billionaire after he co-founded the Home Depot, has served as the chair of the board of trustees since 1999 and has been one of the health system’s largest donors. Fiona Druckenmiller, a vintage jewelry dealer and philanthropist who has served on NYU’s board since 2006, will take over as chair. Although Langone plans to step down as the chair of the board, he will remain a member.

NYU Langone has begun a nationwide search for its next CEO to replace Grossman, said Steve Ritea, a spokesman for the health system.



Amanda D'Ambrosio , 2024-06-14 00:11:38

Source link

Related posts

Trump Urges Republicans to Dismantle Bipartisan Press Freedom Bill: A Call to Action

California Faces Fiery Deluge: Atmospheric River Unleashes Rain, Snow, and Power Outages Across the West Coast

Banana Duct Tape Art Sells for $6.2 Million: The Auction That Shocked New York!

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More